Intentional
Inadvertent
1. Iatrogenic
(a) Suppressive thyroxine dose in thyroid cancer
(b) Excessive thyroxine dose to shrink goiter
(c) Patient’s insistence on higher thyroid hormone dose
2. Factitious
(a) Surreptitious ingestion of thyroid hormone to feign hyperthyroidism
3. Thyroid hormone abuse
(a) Supplements or thyroid hormone/extracts usually taken for the purpose of weight loss, without willful intention to feign hyperthyroidism
1. Medication error (i.e., patient or pharmacy)
2. Accidental ingestion of another person’s or (rarely) pet’s thyroxine dose in place of the patient’s dose
3. Accidental overdose (i.e., children)
4. Meat contamination with thyroid hormone (“hamburger thyrotoxicosis”)
5. Ingestion of herbal/weight loss supplements but unaware that thyroid hormone is an unspecified ingredient
The intentional and surreptitious ingestion of thyroid hormone to feign the diagnosis of hyperthyroidism is factitious thyrotoxicosis. A form of Munchausen’s syndrome, this psychiatric disorder is motivated by the patient’s desire to assume the sick role for emotional gain [2]. This is most commonly observed in young or middle-aged women with a history of childhood emotional deprivation and/or current sexual or relationship problems; in some cases, the patient may carry a diagnosis of borderline personality disorder or post-traumatic stress disorder [3]. Other suggestive historical features may include a connection to the healthcare profession, lack of appropriate concern for health problems, or a past history of feigning illness [2]. On the other hand, thyroid hormone abuse may also be observed in individuals without an underlying psychiatric disorder, usually for the purpose of weight loss [4]. In these cases, the patient’s motivation is not to feign a medical condition, but rather to derive perceived benefits of hyperthyroidism (weight loss, increased energy, etc.) [4].
As challenging as it may be to diagnose factitious thyrotoxicosis, it can be even more difficult to identify cases of inadvertent thyrotoxicosis. In some cases, the problem may be as simple as a pharmacy or patient medication error. For patients already prescribed thyroid hormone, it may be helpful to verify that they are taking the prescribed dose by having them bring in their medications for review and/or contacting their pharmacy. One unusual cause of medication error is inadvertent ingestion of a pet’s thyroxine dose in place of prescribed thyroxine [5]. Accidental thyroxine poisoning has occurred in young children with access to the medication [6, 7]. Rarely, outbreaks of thyrotoxicosis have occurred following consumption of ground beef contaminated with bovine thyroid gland (so-called hamburger thyrotoxicosis) [8].
In recent years, there have been increasing reports of accidental overdose of thyroid hormone caused by weight-reducing herbal medications containing thyroid hormone as a hidden ingredient [9, 10]. The use of herbal or natural supplements is widespread in the USA and these products are not regulated by the FDA. Surprisingly, as many as 7 % of such supplements contain undisclosed substances [9]. It has been estimated that half of patients do not disclose their use of supplements to physicians [9]. Some easily accessible nonprescription supplements taken for the purposes weight loss, energy, or “thyroid support” have been found to contain clinically significant amounts of T3 and T4 [9–11]. Therefore, the use such supplements poses a serious risk of hyperthyroidism-related cardiovascular complications. In some instances, supplements adulterated with thyroid hormone may have a beta-blocker added to mask hyperadrenergic symptoms, which could make recognition of the thyrotoxic patient even more difficult [9]. In patients with underlying thyroid disease, exogenous thyrotoxicosis can complicate the clinical picture and lead to a delay in diagnosis [10].
How the Diagnosis Was Made
The patient described in the case above presented with classic features of hyperthyroidism. Given the absence of a goiter or exophthalmos, a nontender thyroid gland, and low radioiodine uptake, the initial suspicion was that she had painless thyroiditis. The onset of symptoms 18 months after the delivery of her child made postpartum thyroiditis less probable, as this typically occurs at a shorter interval (2–12 months) after delivery.
At the outset, conservative management was recommended with the expectation that the hyperthyroid phase of thyroiditis would resolve within 3–4 months; instead, the hyperthyroidism persisted and progressed over the subsequent 18 months. Repeat radioiodine uptake was persistently low. The differential diagnosis for thyrotoxicosis associated with decreased radioiodine uptake includes various forms of thyroiditis, exogenous thyrotoxicosis, and excess iodine intake (radiographic contrast, amiodarone, iodine supplementation). Table 8.2 summarizes features that distinguish exogenous thyrotoxicosis from these other causes. Struma ovarii was another etiology considered in her case, but this was excluded by absence of ectopic uptake on whole body scan. With a normal urine iodine level, iodine contamination was ruled out as a cause of low radioiodine uptake. The patient was not taking any medications known to cause thyroiditis. The absence of thyroid autoantibodies provided further evidence against underlying thyroid disease.
Table 8.2
Distinguishing exogenous thyrotoxicosis from other causes of thyrotoxicosis associated with decreased radioiodine uptake
Factor | Exogenous thyrotoxicosis | Other causes of thyrotoxicosis associated with decreased radioiodine uptake |
---|---|---|
Thyroid function tests | Low TSH, high free T4, high T3 | Low TSH, high free T4, high T3 |
Ratio of T3/T4 | Suggested by high T3/T4 ratio (>19), but not excluded by low T3/T4 ratio (<16) [12] | T3/T4 ratio usually <16 [12] |
Thyroid autoantibodies | Absent, unless underlying thyroid disease | May be positive in painless or postpartum thyroiditis |
Physical examination | Normal or nonpalpable, nontender thyroid; absence of exophthalmos or other stigmata of Graves’ disease | Thyroid may be enlarged or tender to palpation in some types of thyroiditis |
Inflammatory markers | Normal | Elevated ESR, CRP, leukocytosis, in subacute thyroiditis |
Duration of thyrotoxicosis | Variable, depending on duration of exogenous thyroid hormone intake | Usually 3–4 months in thyroiditis |
24-h radioiodine uptake | Low (usually <1 %); may be higher in patients with underlying autonomy (toxic nodules) | Low (usually <1 %) |
Serum thyroglobulin | Low, but not necessarily undetectable | Normal or high (may be low in presence of antithyroglobulin antibodies) |
Urine iodine | Normal | Very high in cases of excess iodine (i.e., radiographic contrast, amiodarone, iodine supplementation) |
Fecal thyroid hormone measurement | High | Normal |
Since an 18 month phase of hyperthyroidism in the context of thyroiditis would be untenable, the differential diagnosis was narrowed down to exogenous thyrotoxicosis. This was corroborated by the patient’s very low serum thyroglobulin level. Thyroglobulin can be a helpful diagnostic clue in this setting because it is typically low (though not necessarily undetectable) in exogenous thyrotoxicosis, whereas it is high in thyroiditis and endogenous hyperthyroidism [1]. It should be noted that serum thyroglobulin levels may not be suppressed to undetectable levels in all cases of exogenous thyrotoxicosis, particularly in those with adenomatous goiter or persistent thyroid cancer [10]. Regrettably, a thyroglobulin level was not obtained early in this patient’s course, and this may have contributed to the long delay in diagnosis.
In addition, the markedly elevated T3 and T4 concentrations in this case suggested that the patient was either consuming thyroid extract or a combination of synthetic T4/T3. A high total T3/total T4 ratio (>19) in conjunction with low radioiodine uptake is a pattern unique to exogenous thyrotoxicosis resulting from combination T4/T3 ingestion. By contrast, thyroiditis typically results in a lower total T3/total T4 ratio (typically <16) [12]. In clinical practice, the T3/T4 ratio is typically used to distinguish between endogenous hyperthyroidism (i.e., Graves’ disease or toxic adenoma) and destructive thyroiditis, but it has a limited role in distinguishing thyroiditis from exogenous thyrotoxicosis [12]. This is because patients taking pure thyroxine have elevations in both T3 and T4 with a ratio that may overlap with that observed in thyroiditis [12]. In other words, only a high T3/T4 ratio has discriminative value in this context.